Role of Rotational Guided Growth in Management of Increased Femoral Anteversion

NCT ID: NCT06320769

Last Updated: 2024-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-20

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Efficacy of guided growth in coronal plane deformity correction and limb length discrepancy has been well-established. Recently, studies have explored the validity of guided growth in correction of rotational deformity through a modified method of application.

This concept has been validated in animal studies, biomechanical studies and two limited human case series through different methods.

This study evaluates the efficacy of rotational guided growth in management of increased femoral anteversion using three different constructs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is:

1. Evaluate the efficacy of different constructs in correcting increased femoral anteversion clinically and radiographically.
2. Asses possible complications of this new concept including LLD, undesired coronal, sagittal plane deformity and stiffness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Increased Femoral Anteversion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rotational Guided Growth

o On a radiolucent operating table with the child supine, a torniquet is applied. The limb is prepped and draped.

oA Kirschner wire is inserted in midsagittal plane of the distal femoral physis from medial to lateral under fluoroscopic guidance.

After the initial step, One of three Surgical techniques might be used according to surgeon preference and patient age:

* Plate technique
* Non-absorbable suture technique
* Cerclage wire technique

Group Type EXPERIMENTAL

Plate Technique

Intervention Type DEVICE

Using Plates, non-absorbable sutures or cerclage wires to guide the distal femoral physis towards rotational growth to correct deformity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plate Technique

Using Plates, non-absorbable sutures or cerclage wires to guide the distal femoral physis towards rotational growth to correct deformity

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Non-absorbable Suture Technique Cerclage Wire Technique

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with increased femoral anteversion causing in-toeing with decreased agility.
* Aged 8 years and above with at least two years of bone growth remaining.

Exclusion Criteria

* Any patient who underwent previous femoral osteotomy.
* Any patient with sick physis (skeletal dysplasias, post traumatic / post infective physeal damage, active rickets).
* Cerebral Palsy (CP) patients
Minimum Eligible Age

8 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tarek Hassan Abdelaziz, Professor

Role: STUDY_CHAIR

Ain Shams University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Ainshams University

Cairo, El-Waily, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Mohamed Mohamed Abdelghany Badr, Msc

Role: CONTACT

+201060085397

Tarek Hassan Abdelaziz

Role: CONTACT

+201222421760

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tarek Hassan Abdelaziz, Professor

Role: primary

+201222421760

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24101994

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.